4//SEC Filing
Zaeske Adam H. 4
Accession 0001415889-25-010798
CIK 0001802665other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:06 PM ET
Size
8.1 KB
Accession
0001415889-25-010798
Insider Transaction Report
Form 4
Zaeske Adam H.
CHIEF COMMERCIAL OFFICER
Transactions
- Award
Stock Option
2025-04-07+100,000→ 100,000 totalExercise: $28.40Exp: 2035-04-07→ Common Stock (100,000 underlying) - Award
Restricted Stock Units
2025-04-07+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The stock option vests with respect to 25% of the underlying shares on April 7, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0002064712
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:06 PM ET
- Size
- 8.1 KB